Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 4 | Cellular & Molecular Biology Letters

Fig. 4

From: IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development

Fig. 4

IGF2BP3 expression is negatively regulated by miR-320a-3p in bladder cancer. A Correlation analysis between IGF2BP3 mRNA level and miR-320a-3p level in TCGA BLCA. B Correlation analysis between IGF2BP3 mRNA level and miR-320a level in GSE40355. C Construction of a reporter plasmid with the 3′-UTR of the IGF2BP3 gene targeted by miR-320a-3p. D, E Determination of the relative luciferase activity in 293 T cells transfected with the miR-320a-3p mimic, antagomir, or negative control (NC). Vec, vector without UTR sequence. F, G The relative miR-320a-3p level in BFTC905 cells after treatment with miR-320a-3p mimic or antagomir. HK The effect of miR-320a-3p mimic, antagomir on the IGF2BP3 mRNA and protein level in BFTC905 cells. L Comparison of miR-320a-3p levels between normal and bladder cancer tissues in GSE40355 dataset. MO Kaplan–Meier analysis of OS, DSS, and PFI according to miR-320a-3p expression in the TCGA BLCA. Error bars indicate the mean ± sd from three independent experiments. ***p < 0.001, **p < 0.01, *p < 0.05

Back to article page